MA39959A - Procédé de production de cellules progénitrices de foie adulte - Google Patents

Procédé de production de cellules progénitrices de foie adulte

Info

Publication number
MA39959A
MA39959A MA039959A MA39959A MA39959A MA 39959 A MA39959 A MA 39959A MA 039959 A MA039959 A MA 039959A MA 39959 A MA39959 A MA 39959A MA 39959 A MA39959 A MA 39959A
Authority
MA
Morocco
Prior art keywords
cells
progenitor cells
adult liver
liver progenitor
producing
Prior art date
Application number
MA039959A
Other languages
English (en)
Inventor
Tuba Baran
Luca Falciola
Kris Gellynck
Sarah Snykers
Etienne Sokal
Original Assignee
Promethera Biosciences S A /N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2014/068317 external-priority patent/WO2015028577A1/fr
Application filed by Promethera Biosciences S A /N V filed Critical Promethera Biosciences S A /N V
Publication of MA39959A publication Critical patent/MA39959A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)

Abstract

De nouvelles cellules progénitrices de foie adulte (appelées cellules souches h2) ont été caractérisées sur la base d'une série d'activités et de marqueurs biologiques. Des procédés de production de cellules souches h2 permettent d'obtenir ces cellules sous la forme de cellules adhérentes et de grappes de cellules tridimensionnelles en suspension qui peuvent être différenciées en cellules présentant de fortes activités spécifiques au foie et/ou qui peuvent être utilisées pour traiter des maladies hépatiques ou pour évaluer l'efficacité, le métabolisme et/ou la toxicité d'un composé.
MA039959A 2014-08-28 2015-08-28 Procédé de production de cellules progénitrices de foie adulte MA39959A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/068317 WO2015028577A1 (fr) 2013-08-28 2014-08-28 Procédé de production de cellules progénitrices de foie adulte
EP15157664 2015-03-04

Publications (1)

Publication Number Publication Date
MA39959A true MA39959A (fr) 2017-03-15

Family

ID=52705967

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039959A MA39959A (fr) 2014-08-28 2015-08-28 Procédé de production de cellules progénitrices de foie adulte

Country Status (21)

Country Link
US (2) US10538741B2 (fr)
EP (1) EP3140393B1 (fr)
JP (2) JP2017530697A (fr)
KR (2) KR102101060B1 (fr)
CN (1) CN106795489B (fr)
AU (1) AU2015308341B2 (fr)
BR (1) BR112017003996A2 (fr)
CA (1) CA2958851C (fr)
DK (1) DK3140393T3 (fr)
EA (1) EA035214B1 (fr)
ES (1) ES2954834T3 (fr)
FI (1) FI3140393T3 (fr)
IL (1) IL249232B (fr)
LT (1) LT3140393T (fr)
MA (1) MA39959A (fr)
MX (1) MX375678B (fr)
PL (1) PL3140393T3 (fr)
PT (1) PT3140393T (fr)
SA (1) SA517380984B1 (fr)
SG (1) SG11201701109WA (fr)
WO (1) WO2016030525A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
ES2764408T3 (es) 2013-08-28 2020-06-03 Promethera Biosciences S A / N V Procedimiento para la producción de células progenitoras hepáticas adultas
SG10201801654RA (en) 2014-05-28 2018-04-27 Childrens Hospital Med Ct Methods and systems for converting precursor cells into gastric tissues through directed differentiation
KR102101060B1 (ko) 2014-08-28 2020-04-16 프로메테라 바이오사이언시즈 에스.에이./엔.브이. 성체 간 전구 세포의 제조 방법
AU2015331848B2 (en) 2014-10-17 2022-03-03 Children's Hospital Medical Center, D/B/A Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
CN109415685B (zh) 2016-05-05 2023-07-04 儿童医院医疗中心 用于体外制造胃底组织的方法和与其相关的组合物
EP4553082A3 (fr) 2016-11-04 2025-08-20 Children's Hospital Medical Center Compositions d'organoïdes hépatiques et leurs procédés de fabrication et d'utilisation
EP3548507A4 (fr) 2016-12-05 2020-07-15 Children's Hospital Medical Center Organoïdes du côlon et leurs procédés de préparation et d'utilisation
JP7248586B2 (ja) 2017-04-14 2023-03-29 チルドレンズ ホスピタル メディカル センター 複数ドナー幹細胞組成物およびそれを作製する方法
WO2019055345A1 (fr) * 2017-09-12 2019-03-21 Beth Israel Deaconess Medical Center, Inc. Compositions et méthodes permettant de traiter une maladie hépatique et un dysfonctionnement hépatique
EP3694603B1 (fr) 2017-10-10 2026-04-08 Children's Hospital Medical Center Compositions de tissus oesophagiens et/ou d'organoïdes et leurs procédés de fabrication
EP3727394A4 (fr) 2017-12-21 2021-09-08 Children's Hospital Medical Center Organoïdes humains numérisés et méthodes d'utilisation de ceux-ci
JP7530886B2 (ja) * 2018-05-16 2024-08-08 インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） 増殖性肝細胞を培養する方法
EP4678727A3 (fr) 2018-07-26 2026-03-11 Children's Hospital Medical Center Tissus hépato-biliaire-pancréatiques et leurs procédés de fabrication
CA3112026A1 (fr) 2018-09-12 2020-03-19 Children's Hospital Medical Center Compositions d'organoides pour la production de cellules souches hematopoietiques et leurs derives
KR102107057B1 (ko) * 2018-09-21 2020-05-07 오가노이드사이언스 주식회사 간 유래 줄기세포를 포함하는 간 오가노이드의 제조방법 및 이의 용도
CN110982776B (zh) * 2018-09-30 2023-07-04 中国科学院分子细胞科学卓越创新中心 肝细胞的体外扩增培养方法及应用
TW202043463A (zh) 2018-12-14 2020-12-01 比利時商普羅米修亞生物科技股份有限公司 包含表現hla-e之肝先驅細胞之細胞組成物
TW202035682A (zh) 2018-12-14 2020-10-01 比利時商普羅米修亞生物科技股份有限公司 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
US12600943B2 (en) 2019-02-01 2026-04-14 The University Of Hong Kong Innervated organoid compositions and methods of making same
AU2020245045A1 (en) * 2019-03-26 2021-11-18 Promethera Therapeutics Sa Adult liver progenitor cells for treating acute-on-chronic liver failure
WO2020193715A1 (fr) 2019-03-26 2020-10-01 Promethera Biosciences S.A./N.V. Cellules progénitrices du foie adulte pour le traitement d'une stéatose hépatique non alcoolique
JP2022530620A (ja) * 2019-04-30 2022-06-30 プロメセラ セラピューティクス エスエイ ヒト同種肝臓由来前駆細胞の調製
TW202106874A (zh) 2019-04-30 2021-02-16 比利時商普羅米修亞生物科技股份有限公司 人類同種異體肝衍生前驅細胞的製備(一)
AU2020283048A1 (en) 2019-05-31 2021-12-23 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
US12497597B2 (en) 2019-05-31 2025-12-16 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
CN110179970A (zh) * 2019-07-05 2019-08-30 浙江大学 Il-1r2细胞因子在制备治疗肝功能衰竭药剂中的应用
JP2022551293A (ja) 2019-10-09 2022-12-08 セライオン エスアー 血管透過性亢進を特徴とする疾患における肝臓前駆細胞または幹細胞、その溶解物、および／または馴化培地の使用
CN111206013A (zh) * 2020-02-13 2020-05-29 上海交通大学医学院附属仁济医院 一种长时间维持人原代肝细胞的功能状态的培养方法
EP3881853A1 (fr) 2020-03-20 2021-09-22 Promethera Therapeutics Sa Cellules progénitrices allogéniques humaines dérivées du foie à utiliser dans le traitement des maladies pulmonaires inflammatoires et infectieuses et de l'inflammation systémique
WO2021260735A1 (fr) * 2020-06-26 2021-12-30 Ykrita Lifesciences Private Limited Foie latéral artificiel biogénétiquement modifié (ball) ou foie ectopique artificiel biogénétiquement modifié (bael)
WO2023180122A1 (fr) 2022-03-24 2023-09-28 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir la sénescence cellulaire
WO2024200809A1 (fr) 2023-03-31 2024-10-03 Université Catholique de Louvain Utilisation de cellules progénitrices allogéniques humaines dérivées du foie pour traiter et/ou prévenir le carcinome hépatocellulaire
EP4560009A1 (fr) 2023-11-27 2025-05-28 Cellaïon SA Procédé de préparation de cellules isolées dérivées du foie
CN120192915B (zh) * 2025-05-23 2025-09-02 淇嘉科技(苏州)有限公司 多谱系肝类器官代谢性成熟方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129911A (en) 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
US6872389B1 (en) 1999-07-08 2005-03-29 Rhode Island Hospital Liver stem cell
CN1258589C (zh) * 2000-10-03 2006-06-07 北卡罗来纳大学 分离双能肝祖细胞的方法
SE527491C2 (sv) * 2003-12-19 2006-03-21 Cmc Contrast Ab Kontraktsmedelskomposition för magnetisk resonanstomografi för oral administration
US8673635B2 (en) 2005-12-21 2014-03-18 Universite Catholique De Louvain Isolated liver stem cells
ES2359874T5 (es) * 2005-12-21 2014-12-12 Universite Catholique De Louvain Células madre hepáticas aisladas
US8415149B2 (en) * 2010-05-06 2013-04-09 Gwo Xi Stem Cell Applied Technology Co., Ltd. Hepatic progenitor cells and uses thereof
ES2759228T3 (es) * 2013-07-05 2020-05-08 Univ Catholique Louvain Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado
ES2764408T3 (es) * 2013-08-28 2020-06-03 Promethera Biosciences S A / N V Procedimiento para la producción de células progenitoras hepáticas adultas
KR102101060B1 (ko) 2014-08-28 2020-04-16 프로메테라 바이오사이언시즈 에스.에이./엔.브이. 성체 간 전구 세포의 제조 방법

Also Published As

Publication number Publication date
CN106795489A (zh) 2017-05-31
CA2958851A1 (fr) 2016-03-03
EP3140393B1 (fr) 2023-06-14
IL249232B (en) 2020-04-30
US10538741B2 (en) 2020-01-21
US20170240863A1 (en) 2017-08-24
CA2958851C (fr) 2023-05-09
SG11201701109WA (en) 2017-03-30
EA035214B1 (ru) 2020-05-18
JP2017530697A (ja) 2017-10-19
DK3140393T3 (da) 2023-09-18
PL3140393T3 (pl) 2023-11-06
MX2017002667A (es) 2017-10-02
MX375678B (es) 2025-03-06
AU2015308341A1 (en) 2017-03-02
PT3140393T (pt) 2023-09-04
US20200095554A1 (en) 2020-03-26
EA201790357A1 (ru) 2017-08-31
SA517380984B1 (ar) 2022-02-14
US11339373B2 (en) 2022-05-24
IL249232A0 (en) 2017-02-28
EP3140393A1 (fr) 2017-03-15
KR20190003833A (ko) 2019-01-09
JP2020127423A (ja) 2020-08-27
ES2954834T3 (es) 2023-11-27
CN106795489B (zh) 2021-07-06
AU2015308341B2 (en) 2021-09-16
FI3140393T3 (fi) 2023-09-07
WO2016030525A1 (fr) 2016-03-03
KR20170002664A (ko) 2017-01-06
BR112017003996A2 (pt) 2017-12-12
LT3140393T (lt) 2023-09-11
KR102101060B1 (ko) 2020-04-16

Similar Documents

Publication Publication Date Title
SA517380984B1 (ar) طريقة لإنتاج خلايا سليفة في كبد بالغ
MX369514B (es) Metodo para producir celulas progenitoras hepaticas adultas.
IL291373A (en) Methods and systems for growing cells in culture
SG10201810150UA (en) Compositions and methods for enhanced gene expression in cone cells
EP3619302A4 (fr) Compositions et méthodes d'édition de gènes dans des lymphocytes t par crispr/cpf1
MX2017004890A (es) Metodos y composiciones para la generación o el mantenimiento de células pluripotentes.
IL249828A0 (en) Limbal stem cells of cultured mammals, methods of their creation and uses thereof
MX2017008416A (es) Formas solidas de un inhibidor de ask1.
EP4403138A3 (fr) Dispositif et procédé avec fréquence de stimulateur cardiaque réduite lors du remplacement de valvule cardiaque
PH12016500783A1 (en) Suspension and clustering of human pluripotent stem cells for differentation into pancreatic endocrine cells
WO2015134787A3 (fr) Procédés dans lesquels on utilise des molécules synthétiques contenant des randomères
SG10201810723VA (en) Improved t cell compositions
EP3223831A4 (fr) Procédés de génération de podocytes à partir de cellules souches pluripotentes et cellules obtenues selon ces procédés
EP3303382A4 (fr) Compositions et procédés pour traiter des patients avec des cellules mutantes rtk
WO2016012544A3 (fr) Reprogrammation améliorée de cellules ips
PL3443608T3 (pl) Ogniwa elektrochemiczne posiadające zaprojektowane pola przepływu oraz sposoby ich wytwarzania
GB201602974D0 (en) Engineered cells & methods (1)
EP3325608A4 (fr) Procédés et micro-organismes de production de 1,3-butanediol
IL266831B (en) A population of cells for transplantation and a method for its production
SG10201902355VA (en) Ultra-high density cell banking methods
PH12017550064A1 (en) Method of preventing or treating hearing loss
IL256093B (en) Method for multiplying and/or differentiating hematopoietic stem cells into progenitors and uses thereof
MX2015017414A (es) Bacteria acetogenica.
EP3279317A4 (fr) Milieu de culture contenant du fer chelaté pour cellules souches neurales
WO2015175534A3 (fr) Compositions et procédés utilisant des cardiomyocytes dérivés de cellules souches